Benitec Biopharma Limited (BNTC) vs YD Bio Limited (YDES)

Benitec Biopharma Limited and YD Bio Limited are both Biotechnology companies. Benitec Biopharma Limited and YD Bio Limited are of similar size ($336.2M and $332.3M).

Valuation

Metric BNTC YDES Biotechnology median
P/E n/m — 7.88
P/S 5,953.22 — 11.47
P/B 2.52 — 2.52
Price to free cash flow n/m — 21.16
EV/EBITDA n/m — 0.74
EV/Sales 3,555.62 — 10.73
Earnings yield (10.25%) — (28.84%)
Free cash flow yield (3.72%) — (23.03%)

Profitability

Metric BNTC YDES Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (33.21%) — (57.72%)
Return on assets (32.28%) — (49.22%)
Return on invested capital 0.00% — 0.00%

Growth

Metric BNTC YDES Biotechnology median
Revenue growth (TTM) (1.32%) — 5.64%
EPS growth (last fiscal year) 6.83% — —
Revenue growth, 5-year CAGR 4.92% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BNTC YDES Biotechnology median
Debt to equity 0.00 — 0.00
Current ratio 34.00 — 4.73
Net debt to EBITDA 3.52 — 0.96

Dividend

Metric BNTC YDES Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric BNTC YDES Biotechnology median
Market cap 336.24m 332.25m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack